Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy.

Míreanna comhchosúla

• Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.
  de réir: Proks, P, et al.
  Foilsithe / Cruthaithe: (2006)
• Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
  de réir: Pearson, E, et al.
  Foilsithe / Cruthaithe: (2006)
• Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.
  de réir: Tammaro, P, et al.
  Foilsithe / Cruthaithe: (2005)
• Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.
  de réir: Flanagan, SE, et al.
  Foilsithe / Cruthaithe: (2006)
• Neonatal diabetes - The role of KCNJ11 (Kir6.2)
  de réir: Tammaro, P
  Foilsithe / Cruthaithe: (2007)